Kontroll og tilsyn med medisinsk forskning
DOI:
https://doi.org/10.5324/nje.v14i1.247Abstract
En rekke ulike organer fører i dag kontroll med medisinsk forskning i Norge. Det er imidlertid vanskelig, både for forskere og myndigheter, å ha full oversikt over hvilke skjemaer som skal sendes hvor, og hvilken instans som har ansvaret for hva. Organenes virksomhet overlapper til en viss grad hverandre og de er satt til å håndheve et fragmentert og uklart regelverk. Disse forhold kan være et problem, både for forsøkspersoner og forskere, men også for samfunnet for øvrig. Artikkelforfatterne er tilknyttet Nylennautvalget, som er oppnevnt av Regjeringen for å gjennomgå reguleringen av medisinsk forskning som involverer mennesker og humant biologisk materiale. Utvalget skal komme med forslag til tiltak som kan sikre en hensiktsmessig og klar regulering av medisinsk forskning
ENGLISH SUMMARY
A great many agencies monitor medical research in Norway. Both researchers and public authorities find it hard to get an overview over the current system. The agencies’ scopes are overlapping and they apply a fragmentary and unclear set of rules. Those circumstances may be a problem for research subjects and researchers, as well as for the society at large. The authors are engaged in the Nylennautvalget, a Committee of independent national experts appointed by the Norwegian government to evaluate the regulation of medical research involving human subjects and human material. The Committee is asked to recommend initiatives that may secure a clear and adequate regulation of medical research.
Downloads
Downloads
Published
How to Cite
Issue
Section
License
Norsk Epidemiologi licenses all content of the journal under a Creative Commons Attribution (CC-BY) licence. This means, among other things, that anyone is free to copy and distribute the content, as long as they give proper credit to the author(s) and the journal. For further information, see Creative Commons website for human readable or lawyer readable versions.
Authors who publish with this journal agree to the following terms:
1. Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
2. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
3. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
